A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Objective: Methylphenidate (MPH) is efficacious in reducing symptoms of attention-deficit/hyperactivity disorder (ADHD), but there are no data about the efficacy and safety of its new formulation (ORADUR(®)-MPH extended release, ORADUR-MPH) in patients with ADHD, which is the study objective. Method...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu-Shu, Yeh, Chin-Bin, Chen, Chin-Hung, Shang, Chi-Yung, Gau, Susan Shur-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066345/
https://www.ncbi.nlm.nih.gov/pubmed/33395356
http://dx.doi.org/10.1089/cap.2020.0104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066345/
https://www.ncbi.nlm.nih.gov/pubmed/33395356
http://dx.doi.org/10.1089/cap.2020.0104

Ejemplares similares